Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating disulfiram in combination with chemotherapy for patients with refractory solid tumors or metastatic pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating metronomic capecitabine with camrelizumab and apatinib mesylate for advanced pancreatic cancer; the study …
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer [Phase 2]
Phase II randomized study of mFOLFIRINOX with or without ramucirumab in advanced pancreatic cancer; results posted in 2025.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of surufatinib and camrelizumab with AS as first-line therapy for advanced metastatic …
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions [NA]
This entry reports a clinical trial evaluating Joint-AI for diagnosing pancreatic solid lesions; the study is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus has launched an Expanded Access Program to provide Botensilimab and Balstilimab to patients before regulatory approval. The program t…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer [EARLY_Phase 1]
An early-phase trial evaluating endoscopic ultrasound-guided intratumoral CAR-NK cell therapy for advanced, non-resectable pancreatic cancer…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial assessing sequential NKG2D CAR-NK cell therapy as second-line chemotherapy for non-resectable pancreati…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab [Phase 1]
Phase 1 trial evaluating dasatinib to prevent oxaliplatin-induced neuropathy in patients with metastatic gastrointestinal cancers receiving …
-
CLINICAL_TRIALS withdrawal · 2024-12-27Clinical Trial Update: GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial of gemcitabine plus nab-paclitaxel and losartan followed by stereotactic radiotherapy for locally advanced pancreatic cancer…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
This clinical trial update describes a study comparing questionnaires versus motion trackers to assess physical activity in cancer patients …
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors [Phase 1, Phase 2]
An update on the Phase 1/2 study of CYT-0851 in B-cell malignancies and advanced solid tumors, noting completion of Phase 1/2 cohorts.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC [Phase 2]
A Phase 2 clinical trial update evaluating nanoliposomal irinotecan with XELOX plus cadonilimab (AK104) as first-line treatment for advanced…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
This clinical trial is evaluating whether the neutrophil-to-lymphocyte ratio and CA 19-9 levels can predict perineural invasion in pancreati…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 dose-escalation study evaluating stereotactic body radiotherapy following induction chemotherapy for locally advanced pancreatic c…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study of CEND-1 with neoadjuvant FOLFIRINOX, with or without panitumumab, in colon and pancreatic cance…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients [NA]
A Sun Yat-sen University-sponsored clinical trial is currently recruiting to evaluate whether oral immunonutrition can reduce acute toxicity…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: A CR-UK Phase I Trial of LY3143921 [Phase 1]
Phase I trial update for LY3143921 sponsored by Cancer Research UK; the study is Active Not Recruiting and explores multiple cancer indicati…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer [Phase 2]
Clinical trial update showing AK104 in combination with chemotherapy as first-line treatment for advanced pancreatic cancer in a Phase 2 stu…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]
This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy [Phase 1, Phase 2]
Phase 1/2 study of the NANT pancreatic cancer vaccine by ImmunityBio, in patients who progressed on or after standard therapy, has been term…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
Ongoing clinical trial evaluating Ga-68 grazytracer PET imaging to monitor responses to immunotherapy in pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Navigating the Learning Curve of Robotic Pancreatoduodenectomy: Feasibility, Proficiency, and Mastery in a First-generation Surgeon
A completed University of Pisa study examines the feasibility, learning curve, and mastery of robotic pancreatoduodenectomy performed by a f…